MarketResearchReportStore adds “Shionogi & Co Ltd – Product Pipeline Review – 2016″ latest studies, published in March 2017. It is a professional and in-depth study on the current state.
For a sample of this report, please email at: Shirley@marketresearchreportstore.com
‘Shionogi & Co Ltd – Product Pipeline Review – 2016’, provides an overview of the Shionogi & Co Ltd’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Shionogi & Co Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from The proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
- The report provides a snapshot of the pipeline therapeutic landscape of Shionogi & Co Ltd
- The report provides overview of Shionogi & Co Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Shionogi & Co Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Shionogi & Co Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Request Sample Copy, please email at: Shirley@marketresearchreportstore.com
Table Of Contents
Shionogi & Co Ltd Snapshot 9
Shionogi & Co Ltd Overview 9
Key Facts 9
Shionogi & Co Ltd – Research and Development Overview 10
Key Therapeutic Areas 10
Shionogi & Co Ltd – Pipeline Review 14
Pipeline Products by Stage of Development 14
Pipeline Products – Monotherapy 15
Pipeline Products – Combination Treatment Modalities 16
Pipeline Products – Partnered Products 17
Partnered Products/Combination Treatment Modalities 18
Pipeline Products – Out-Licensed Products 19
Out-Licensed Products/Combination Treatment Modalities 20
Shionogi & Co Ltd – Pipeline Products Glance 21
Shionogi & Co Ltd – Late Stage Pipeline Products 21
Pre-Registration Products/Combination Treatment Modalities 21
Phase III Products/Combination Treatment Modalities 22
Shionogi & Co Ltd – Clinical Stage Pipeline Products 23
Phase II Products/Combination Treatment Modalities 23
Phase I Products/Combination Treatment Modalities 24
Shionogi & Co Ltd – Early Stage Pipeline Products 25
Preclinical Products/Combination Treatment Modalities 25
Discovery Products/Combination Treatment Modalities 26
Shionogi & Co Ltd – Drug Profiles 27
A-2NTX – Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
AMG-0101 – Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
asapiprant – Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
cefiderocol – Drug Profile 32
Product Description 32
Mechanism Of Action 32
Browse Complete Report with TOC @
For report sample or more information, please feel free to contact us:
Shirley | Sales Director
Call: +00-1-626-3463946 - U.S
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best.